HRMY
Harmony BiosciencesCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
The post-earnings bull case is that Harmony preserved its key de-risking signal at T+1: WAKIX still grew 17% year over year, full-year revenue guidance stayed above $1 billion, liquidity remained strong at $870.5 million, and management laid out multiple franchise-extension shots on goal around Pitolisant GR, Pitolisant HD, BP-205, and EPX-100 [#8-K-2026-05-07].
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.0.
What can break
Cost of product sold rose to 20.7% of revenue, driven by new royalties tied to the Novitium license agreement, which can pressure margins even if revenue grows [#8-K-2026-05-07].
Momentum
42
Value
71
Sentiment
53
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $33.00 · Bull $40.00 · Bear $24.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-08 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $42.00
Why
Momentum42 · Δ7d -1.5
Value71 · Δ7d +0.0
Sentiment53 · Δ7d -2.3
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
42
34% active weight
Current posture
7d trendSoftening
Δ7d
-1.5
Δ21d
-5.5
Value
71
32% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.2
Sentiment
53
33% active weight
Current posture
7d trendSoftening
Δ7d
-2.3
Δ21d
+2.5
Why this grade
Composite grade C. Momentum 42.3 / Value 71.4 / Sentiment 52.5
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$1.79B
Beta
0.84
Shares Out
57.6M
P/E (TTM)
11.6
P/S (TTM)
2.56
P/FCF (TTM)
7.13
Rev YoY
+28.7%
EPS YoY
+9.2%
Gross Margin
+77.7%
Op Margin
+27.3%
Net Debt
-$287.92M
Current Ratio
3.75
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology